Dashboard
Manage Tickers

TGTX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ihc-wainwright--co-assumes-tg-therapeutics-at-buy-announces-price-target-of-60
IHC Wainwright & Co. Assumes TG Therapeuti...
10/06/2025 10:47:28

HC Wainwright & Co. analyst Emily Bodnar assumes TG Therapeutics (NASDAQ:TGTX) with a Buy rating and announces Price Tar...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/01/2025 17:35:33

tg-therapeutics-reports-near-zero-relapse-rate-after-6-years-of-briumvi-treatment-in-multiple-sclerosis-with-no-new-safety-signals
TG Therapeutics Reports Near-Zero Relapse ...
09/24/2025 13:12:08

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring e...

b-riley-securities-maintains-buy-on-tg-therapeutics-raises-price-target-to-55
B. Riley Securities Maintains Buy on TG Th...
09/17/2025 18:12:00

B. Riley Securities analyst Mayank Mamtani maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target fr...

tg-therapeutics-to-present-long-term-briumvi-data-in-relapsing-ms-at-ectrims-2025-including-six-year-ultimate-i--ii-results-and-real-world-enable-study-updates
TG Therapeutics To Present Long-Term BRIUM...
09/10/2025 11:36:36

tg-therapeutics-to-present-long-term-briumvi-data-in-relapsing-ms-at-ectrims-2025-including-six-year-ultimate-i--ii-results-and-real-world-enable-study-updates
TG Therapeutics To Present Long-Term BRIUM...
09/10/2025 11:33:25

tg-commenced-enrollment-phase-3-trial-for-subcutaneous-briumvi
TG Commenced Enrollment Phase 3 Trial For ...
09/08/2025 11:30:41

tg-therapeutics-ceo-voices-strong-conviction-in-briumvi-with-new-100-million-buyback
TG Therapeutics CEO Voices Strong Convicti...
09/03/2025 16:40:49

TG Therapeutics' stock rose after completing a $100 million buyback and approving another $100 million plan, reinforcing co...

tg-therapeutics-authorizes-new-100m-repurchase-program
TG Therapeutics Authorizes New $100M Repur...
09/03/2025 11:31:56

tg-therapeutics-files-for-mixed-shelf-offering-size-not-disclosed
TG Therapeutics Files For Mixed Shelf Offe...
08/08/2025 21:27:30

-SEC Filing

crude-oil-falls-15-on-semiconductor-shares-plunge-after-q2-results
Crude Oil Falls 1.5%; ON Semiconductor Sha...
08/04/2025 17:33:21

briumvis-strong-sales-cant-stop-tg-therapeutics-stock-slide
Briumvi's Strong Sales Can't Stop TG Thera...
08/04/2025 17:14:25

TG Therapeutics missed Q2 earnings and revenue expectations but raised its 2025 Briumvi sales guidance following strong global ...

tg-therapeutics-raises-fy2025-sales-guidance-from-575000m-to-585000m-vs-596120m-est
TG Therapeutics Raises FY2025 Sales Guidan...
08/04/2025 11:01:26

TG Therapeutics (NASDAQ:TGTX) raises FY2025 sales outlook from $575.000 million to $585.000 million vs $596.120 million estimate.

tg-therapeutics-q2-eps-017-misses-019-estimate-sales-141148m-miss-146422m-estimate
TG Therapeutics Q2 EPS $0.17 Misses $0.19 ...
08/04/2025 11:00:44

TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0....

Core News & Articles
Earnings Scheduled For August 4, 2025
08/04/2025 08:32:29

whats-next-tg-therapeuticss-earnings-preview
What's Next: TG Therapeutics's Earnings Pr...
08/01/2025 19:03:11

cramer-backs-this-mining-giant-after-16b-bet
Cramer Backs This Mining Giant After $1.6B...
07/01/2025 12:11:40

Jim Cramer recommends buying Rio Tinto due to its high yield. TG Therapeutics is also a buy, with strong first-quarter sales an...

tg-therapeutics-presents-data-highlighting-briumvi-in-patients-with-relapsing-forms-of-multiple-sclerosis-at-2025-cmsc-annual-meeting
TG Therapeutics Presents Data Highlighting...
05/30/2025 11:31:31

tg-therapeutics-announces-upcoming-schedule-of-presentations-highlighting-briumvi-data-in-patients-with-rms-at-2025-cmsc-annual-meeting
TG Therapeutics Announces Upcoming Schedul...
05/27/2025 11:37:40

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-...

tg-therapeutics-falls-short-on-earnings-but-briumvi-sales-steal-the-show
TG Therapeutics Falls Short On Earnings, B...
05/05/2025 20:37:15

TG Therapeutics posts Q1 profit and nearly doubles revenue, driven by rising Briumvi sales and higher full-year guidance for 2025.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION